These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23420501)

  • 21. A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR).
    Chan TF; Carvalho J; Riles L; Zheng XF
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13227-32. PubMed ID: 11078525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulatory networks in Saccharomyces cerevisiae.
    Lee TI; Rinaldi NJ; Robert F; Odom DT; Bar-Joseph Z; Gerber GK; Hannett NM; Harbison CT; Thompson CM; Simon I; Zeitlinger J; Jennings EG; Murray HL; Gordon DB; Ren B; Wyrick JJ; Tagne JB; Volkert TL; Fraenkel E; Gifford DK; Young RA
    Science; 2002 Oct; 298(5594):799-804. PubMed ID: 12399584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Array-based synthetic genetic screens to map bacterial pathways and functional networks in Escherichia coli.
    Babu M; Gagarinova A; Greenblatt J; Emili A
    Methods Mol Biol; 2011; 765():125-53. PubMed ID: 21815091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemogenomic approaches to elucidation of gene function and genetic pathways.
    Pierce SE; Davis RW; Nislow C; Giaever G
    Methods Mol Biol; 2009; 548():115-43. PubMed ID: 19521822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting bioprocess targets of chemical compounds through integration of chemical-genetic and genetic interactions.
    Simpkins SW; Nelson J; Deshpande R; Li SC; Piotrowski JS; Wilson EH; Gebre AA; Safizadeh H; Okamoto R; Yoshimura M; Costanzo M; Yashiroda Y; Ohya Y; Osada H; Yoshida M; Boone C; Myers CL
    PLoS Comput Biol; 2018 Oct; 14(10):e1006532. PubMed ID: 30376562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of drug targets by chemogenomic and metabolomic profiling in yeast.
    Wu M; Zheng M; Zhang W; Suresh S; Schlecht U; Fitch WL; Aronova S; Baumann S; Davis R; St Onge R; Dill DL; Peltz G
    Pharmacogenet Genomics; 2012 Dec; 22(12):877-86. PubMed ID: 23076370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AVID: an integrative framework for discovering functional relationships among proteins.
    Jiang T; Keating AE
    BMC Bioinformatics; 2005 Jun; 6():136. PubMed ID: 15929793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NetwoRx: connecting drugs to networks and phenotypes in Saccharomyces cerevisiae.
    Fortney K; Xie W; Kotlyar M; Griesman J; Kotseruba Y; Jurisica I
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D720-7. PubMed ID: 23203867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. dSLAM analysis of genome-wide genetic interactions in Saccharomyces cerevisiae.
    Pan X; Yuan DS; Ooi SL; Wang X; Sookhai-Mahadeo S; Meluh P; Boeke JD
    Methods; 2007 Feb; 41(2):206-21. PubMed ID: 17189863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways.
    Parsons AB; Brost RL; Ding H; Li Z; Zhang C; Sheikh B; Brown GW; Kane PM; Hughes TR; Boone C
    Nat Biotechnol; 2004 Jan; 22(1):62-9. PubMed ID: 14661025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis.
    Tang J; Szwajda A; Shakyawar S; Xu T; Hintsanen P; Wennerberg K; Aittokallio T
    J Chem Inf Model; 2014 Mar; 54(3):735-43. PubMed ID: 24521231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yeast cells as tools for target-oriented screening.
    Munder T; Hinnen A
    Appl Microbiol Biotechnol; 1999 Sep; 52(3):311-20. PubMed ID: 10531642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical genetics: budding yeast as a platform for drug discovery and mapping of genetic pathways.
    Enserink JM
    Molecules; 2012 Aug; 17(8):9258-73. PubMed ID: 22858845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey of yeast genomic assays for drug and target discovery.
    Smith AM; Ammar R; Nislow C; Giaever G
    Pharmacol Ther; 2010 Aug; 127(2):156-64. PubMed ID: 20546776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical genomic profiling via barcode sequencing to predict compound mode of action.
    Piotrowski JS; Simpkins SW; Li SC; Deshpande R; McIlwain SJ; Ong IM; Myers CL; Boone C; Andersen RJ
    Methods Mol Biol; 2015; 1263():299-318. PubMed ID: 25618354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yeast as a tool to identify anti-aging compounds.
    Zimmermann A; Hofer S; Pendl T; Kainz K; Madeo F; Carmona-Gutierrez D
    FEMS Yeast Res; 2018 Sep; 18(6):. PubMed ID: 29905792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contextual data integration in drug discovery.
    Yuryev A
    Expert Opin Drug Discov; 2012 Aug; 7(8):659-66. PubMed ID: 22657736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic chemical-genetic and chemical-chemical interaction datasets for prediction of compound synergism.
    Wildenhain J; Spitzer M; Dolma S; Jarvik N; White R; Roy M; Griffiths E; Bellows DS; Wright GD; Tyers M
    Sci Data; 2016 Nov; 3():160095. PubMed ID: 27874849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Employing Cross-Species Approaches to Construct Humanized Genetic Interaction Networks.
    Jeusset LM; McManus KJ
    Methods Mol Biol; 2021; 2381():115-133. PubMed ID: 34590273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Searching for synergies: matrix algebraic approaches for efficient pair screening.
    Gerlee P; Schmidt L; Monsefi N; Kling T; Jörnsten R; Nelander S
    PLoS One; 2013; 8(7):e68598. PubMed ID: 23935877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.